SHH · 688799.SS
Hunan Warrant Pharmaceutical Co.,Ltd
CN¥47.07-CN¥0.91 (-1.9%)
Hunan Warrant Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.01% below the high.
Loading market information…
SHZ · 000078.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shenzhen Neptunus Bioengineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen Neptunus Bioengineering Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shenzhen Neptunus Bioengineering Co., Ltd. is a pharmaceutical enterprise primarily active in China, focusing on the research, development, production, and sale of various medicinal products. Its offerings span therapeutic categories such as anti-cancer treatments, cardiovascular and cerebrovascular medications, and pharmaceuticals derived from marine sources. Founded in 1989, the company is headquartered in Shenzhen, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥47.07-CN¥0.91 (-1.9%)
Hunan Warrant Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.01% below the high.
CN¥13.36+CN¥0.15 (+1.14%)
Chongqing Pharscin Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.67% below the high.
CN¥26.28+CN¥0.06 (+0.23%)
Jiangsu Jibeier Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.89% below the high.
CN¥4.77+CN¥0.08 (+1.71%)
Shanghai Kaibao Pharmaceutical CO.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.54% below the high.
CN¥4.66-CN¥0.01 (-0.21%)
Shanxi Zhendong Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.87% below the high.
CN¥3.96+CN¥0.02 (+0.51%)
Hainan Haiyao Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
CN¥3.99+CN¥0.00 (0.0%)
Luoxin Pharmaceuticals Group Stock Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.44% below the high.
CN¥12.62-CN¥0.17 (-1.33%)
Jiangsu Lianhuan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 60.89% below the high.
